<DOC>
	<DOC>NCT01949753</DOC>
	<brief_summary>Characterization of the influence of pregnenolone vs. placebo on subjective distress and autonomic functioning during cognitive-behavioral exposure therapy in patients with obsessive-compulsive disorder.</brief_summary>
	<brief_title>Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder</brief_title>
	<detailed_description>Main out-come parameters: Inter-session habituation as per SUD (100 mm VAS), Y-BOCS Secondary out-come parameter: HF/LF of HRV, Salivary epinephrine</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>OCD according to DSMIV criteria. Acute suicidality psychotic disorders, bipolar disorder substance dependency organic brain disorder pregnancy lactation tuberculosis gastric/duodenal ulcer diabetes mellitus acute inflammation autoimmune disorders arterial hypertension therapy with glucocorticoids (up to 4 weeks ago)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Obsessive-compulsive disorder (OCD)</keyword>
	<keyword>Exposure therapy</keyword>
	<keyword>Extinction learning</keyword>
	<keyword>Pregnenolone</keyword>
</DOC>